These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 1685016

  • 21. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
    Le Contel C, Temime N, Charron DJ, Parant MA.
    J Immunol; 1993 May 15; 150(10):4541-9. PubMed ID: 8482846
    [Abstract] [Full Text] [Related]

  • 22. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F, McGeady ML, Kim N, Basolo F, Hynes N, Langton BC, Yokozaki H, Saeki T, Elliott JW, Masui H.
    Cell Growth Differ; 1990 Sep 15; 1(9):407-20. PubMed ID: 1981145
    [Abstract] [Full Text] [Related]

  • 23. Neu and its ligands: from an oncogene to neural factors.
    Peles E, Yarden Y.
    Bioessays; 1993 Dec 15; 15(12):815-24. PubMed ID: 7908191
    [Abstract] [Full Text] [Related]

  • 24. Macrophage activation by muramyl dipeptide bound to neoglycoproteins and glycosylated polymers: cytotoxic factor production.
    Petit C, Monsigny M, Roche AC.
    J Biol Response Mod; 1990 Feb 15; 9(1):33-43. PubMed ID: 2319259
    [Abstract] [Full Text] [Related]

  • 25. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A, Thraves PJ, Dritschilo A, Notario V.
    Oncogene; 1996 Oct 17; 13(8):1755-63. PubMed ID: 8895522
    [Abstract] [Full Text] [Related]

  • 26. Absence of autophosphorylation site Y882 in the p185neu oncogene product correlates with a reduction of transforming potential.
    Zhang HT, O'Rourke DM, Zhao H, Murali R, Mikami Y, Davis JG, Greene MI, Qian X.
    Oncogene; 1998 Jun 04; 16(22):2835-42. PubMed ID: 9671404
    [Abstract] [Full Text] [Related]

  • 27. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
    Saiki I, Fidler IJ.
    J Immunol; 1985 Jul 04; 135(1):684-8. PubMed ID: 3923117
    [Abstract] [Full Text] [Related]

  • 28. MDP(Lysyl)GDP, a nontoxic muramyl dipeptide derivative, inhibits cytokine production by activated macrophages and protects mice from phorbol ester- and oxazolone-induced inflammation.
    Zunic M, Bahr GM, Mudde GC, Meingassner JG, Lam C.
    J Invest Dermatol; 1998 Jul 04; 111(1):77-82. PubMed ID: 9665390
    [Abstract] [Full Text] [Related]

  • 29. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
    Fidler IJ, Fogler WE, Kleinerman ES, Saiki I.
    J Immunol; 1985 Dec 04; 135(6):4289-96. PubMed ID: 3934281
    [Abstract] [Full Text] [Related]

  • 30. Polymorphic changes of cell phenotype caused by elevated expression of an exogenous NEU proto-oncogene.
    Tarakhovsky AM, Resnikov M, Zaichuk T, Tugusheva MV, Butenko ZA, Prassolov VS.
    Oncogene; 1990 Mar 04; 5(3):405-10. PubMed ID: 1969137
    [Abstract] [Full Text] [Related]

  • 31. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
    Comoglio PM.
    EXS; 1993 Mar 04; 65():131-65. PubMed ID: 8380735
    [Abstract] [Full Text] [Related]

  • 32. Tyrosine phosphorylation of Shc proteins and formation of Shc/Grb2 complex correlate to the transformation of NIH3T3 cells mediated by the point-mutation activated neu.
    Xie Y, Li K, Hung MC.
    Oncogene; 1995 Jun 15; 10(12):2409-13. PubMed ID: 7784091
    [Abstract] [Full Text] [Related]

  • 33. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
    Reisser D, Jeannin JF, Martin F.
    C R Seances Acad Sci III; 1982 Nov 08; 295(8):485-8. PubMed ID: 6819063
    [Abstract] [Full Text] [Related]

  • 34. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.
    Weiner DB, Liu J, Cohen JA, Williams WV, Greene MI.
    Nature; 1989 May 18; 339(6221):230-1. PubMed ID: 2654648
    [Abstract] [Full Text] [Related]

  • 35. Regulation by EGF is maintained in an overexpressed chimeric EGFR/neu receptor tyrosine kinase.
    Lehväslaiho H, Sistonen L, diRenzo F, Partanen J, Comoglio P, Hölttä E, Alitalo K.
    J Cell Biochem; 1990 Mar 18; 42(3):123-33. PubMed ID: 1969420
    [Abstract] [Full Text] [Related]

  • 36. Muramyl dipeptide and mononuclear cell supernatant induce Langhans-type cells from human monocytes.
    Mizuno K, Okamoto H, Horio T.
    J Leukoc Biol; 2001 Sep 18; 70(3):386-94. PubMed ID: 11527988
    [Abstract] [Full Text] [Related]

  • 37. Intermolecular association and trans-phosphorylation of different neu-kinase forms permit SH2-dependent signaling and oncogenic transformation.
    Qian X, Dougall WC, Fei Z, Greene MI.
    Oncogene; 1995 Jan 05; 10(1):211-9. PubMed ID: 7824275
    [Abstract] [Full Text] [Related]

  • 38. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP, Langton BC, Dilts CA.
    Mol Carcinog; 1996 Feb 05; 15(2):134-43. PubMed ID: 8599580
    [Abstract] [Full Text] [Related]

  • 39. The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand.
    Lonardo F, Di Marco E, King CR, Pierce JH, Segatto O, Aaronson SA, Di Fiore PP.
    New Biol; 1990 Nov 05; 2(11):992-1003. PubMed ID: 1983208
    [Abstract] [Full Text] [Related]

  • 40. Similar early gene responses to ligand-activated EGFR and neu tyrosine kinases in NIH3T3 cells.
    Koskinen P, Lehväslaiho H, MacDonald-Bravo H, Alitalo K, Bravo R.
    Oncogene; 1990 Apr 05; 5(4):615-8. PubMed ID: 1970155
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.